These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37201925)

  • 1. Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
    Bektan Kanat B; Ulugerger Avci G; Bayramlar OF; Unal D; Sonmez O; Bolayirli IM; Doventas A; Erdincler DS; Yavuzer H
    Ann Geriatr Med Res; 2023 Jun; 27(2):151-157. PubMed ID: 37201925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is determination of matrix metalloproteinases and their tissue inhibitors serum concentrations useful in patients with gastroenteropancreatic and bronchopulmonary neuroendocrine neoplasms?
    Blicharz-Dorniak J; Kos-Kudła B; Foltyn W; Kajdaniuk D; Marek B; Zemczak A; Strzelczyk J
    Endokrynol Pol; 2012; 63(6):470-6. PubMed ID: 23339005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High variability in MMP2/TIMP2 and MMP9/TIMP1 expression in secondary liver tumors.
    Avădanei R; Căruntu ID; Amălinei C; Lozneanu L; Balan R; Grigoraş A; Ciobanu Apostol D; Giuşcă SE
    Rom J Morphol Embryol; 2013; 54(3):479-85. PubMed ID: 24068394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma MMP-9 and TIMP-1 levels on ICU admission are associated with 30-day survival.
    Jordakieva G; Budge-Wolfram RM; Budinsky AC; Nikfardjam M; Delle-Karth G; Girard A; Godnic-Cvar J; Crevenna R; Heinz G
    Wien Klin Wochenschr; 2021 Feb; 133(3-4):86-95. PubMed ID: 31932967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.
    Piechota-Polanczyk A; Demyanets S; Mittlboeck M; Hofmann M; Domenig CM; Neumayer C; Wojta J; Klinger M; Nanobachvili J; Huk I
    Eur J Vasc Endovasc Surg; 2015 May; 49(5):549-55. PubMed ID: 25800096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
    Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
    BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.
    Ashworth Briggs EL; Toh T; Eri R; Hewitt AW; Cook AL
    Mol Vis; 2015; 21():1162-72. PubMed ID: 26539028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MMP and TIMP mRNA in peripheral blood leukocytes of patients with invasive ductal carcinoma of the breast.
    Wieczorek E; Galicki M; Tomasik B; Krol M; Jablonska E; Fendler W; Gromadzinska J; Morawiec Z; Wasowicz W; Reszka E
    Int J Biol Markers; 2016 Jul; 31(3):e309-16. PubMed ID: 27032379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
    Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
    Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension.
    Wetzl V; Tiede SL; Faerber L; Weissmann N; Schermuly RT; Ghofrani HA; Gall H
    Lung; 2017 Aug; 195(4):489-496. PubMed ID: 28516393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.
    Duits FH; Hernandez-Guillamon M; Montaner J; Goos JD; Montañola A; Wattjes MP; Barkhof F; Scheltens P; Teunissen CE; van der Flier WM
    J Alzheimers Dis; 2015; 48(3):711-20. PubMed ID: 26402072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture.
    Fortunato SJ; Menon R; Lombardi SJ
    J Perinat Med; 1999; 27(5):362-8. PubMed ID: 10642956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC Study.
    Piccardi B; Palumbo V; Nesi M; Nencini P; Gori AM; Giusti B; Pracucci G; Tonelli P; Innocenti E; Sereni A; Sticchi E; Toni D; Bovi P; Guidotti M; Tola MR; Consoli D; Micieli G; Tassi R; Orlandi G; Perini F; Marcello N; Nucera A; Massaro F; DeLodovici ML; Bono G; Sessa M; Abbate R; Inzitari D
    Front Neurol; 2015; 6():121. PubMed ID: 26074872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.
    Gong YL; Xu GM; Huang WD; Chen LB
    J Surg Oncol; 2000 Feb; 73(2):95-9. PubMed ID: 10694645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a vegetable extract from Lupinus albus (LU105) on the production of matrix metalloproteinases (MMP1, MMP2, MMP9) and tissue inhibitor of metalloproteinases (TIMP1, TIMP2) by human gingival fibroblasts in culture.
    Gaultier F; Foucault-Bertaud A; Lamy E; Ejeil AL; Dridi SM; Piccardi N; Piccirilli A; Msika P; Godeau G; Gogly B
    Clin Oral Investig; 2003 Dec; 7(4):198-205. PubMed ID: 12802622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.